NCT04591132

Brief Summary

Objectives: To generate pilot data to investigate the feasibility and the potential use in clinical practice of technology based objective measures of motor performances in patients affected by different movement disorders. To correlate kinematics findings with demographic and clinical details. Trial design and methods: Participants enrolled in prof. Bhatia's movement disorders clinic, will be classifies according to the main movement disorder, specifically, tremor, parkinsonism, dystonia, chorea, ataxia. In the study visit (one day only), they will undergo a clinical evaluation using the appropriate clinical scales (respectively, Fahn-Tolosa-Marin tremor rating scale, MDS-UPDRS Part III, Toronto Western Spasmodic Torticollis Rating Scale 2, Unified Hungtington Disease Rating scale and Scale for the Assessment and Rating of Ataxia) and a kinematic evaluation, using wearables and an infra-red and LED markers system. Then the protocol is concluded and they will continue the routine clinical follow-up

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 19, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

October 19, 2020

Status Verified

October 1, 2020

Enrollment Period

1.9 years

First QC Date

May 29, 2020

Last Update Submit

October 15, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • gait metrics

    gait cycles measures (step length, phase duration, number of steps) practice of technology based objective measures of motor performances in patients affected by different movement disorders, to objectively evaluate the disease burden, the efficacy of therapeutic interventions and having a deeper phenotyping of motor disabilities.

    up to 6 weeks after enrolment

  • tremor peak frequence

    fourier analysis for peak frequence of tremor

    up to 6 weeks after enrolment

  • neck ROM

    range of motion of the neck in x,y and z axis

    up to 6 weeks after enrolment

  • bradykinesia evaluation

    amplitude of repeated limb movements over time

    up to 6 weeks after enrolment

Secondary Outcomes (1)

  • correlation with UPDRS gait Item

    up to 6 weeks after enrolment

Study Arms (1)

kinematic analysis

EXPERIMENTAL

each patient with a diagnosis of parkinsonism, ataxia, chorea, dystonia or tremor will be asked to perform some motor tasks routinely used in clinical evaluation wearing inertial sensors.

Device: kinematic analysis

Interventions

motor tasks appropriate for each diagnosis will be recorder with wearable inertial sensors

kinematic analysis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of parkinsonism and/or dystonia and/or tremor due to:
  • idiopatic parkinson's disease
  • atypical parkinsonism
  • sporadic or inherited/genetic dystonia
  • young-onset Parkinson's disease
  • Ataxia syndrome
  • Choereic syndrome
  • Essential tremor
  • Dystonic tremor
  • to 80 years of age
  • Willing and able to provide informed consent
  • able to walk unassisted

You may not qualify if:

  • Change in pharmacological therapy in the last 3 months.
  • Orthopaedical comorbidities affecting gait or posture.
  • Cognitive deficit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Movement Disorders

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Central Study Contacts

kailash P Bhatia

CONTACT

giulia di lazzaro

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2020

First Posted

October 19, 2020

Study Start

November 1, 2020

Primary Completion

October 1, 2022

Study Completion

October 1, 2023

Last Updated

October 19, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share